Takara Bio Inc
TSE:4974
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Takara Bio Inc
Takara Bio Inc
Current Portion of Long-Term Debt
Takara Bio Inc
Current Portion of Long-Term Debt Peer Comparison
2160
4587
2929
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takara Bio Inc
TSE:4974
|
Current Portion of Long-Term Debt
¥180m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
GNI Group Ltd
TSE:2160
|
Current Portion of Long-Term Debt
¥4.6B
|
CAGR 3-Years
60%
|
CAGR 5-Years
33%
|
CAGR 10-Years
98%
|
|
|
PeptiDream Inc
TSE:4587
|
Current Portion of Long-Term Debt
¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Current Portion of Long-Term Debt
¥872m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
101%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
StemRIM Inc
TSE:4599
|
Current Portion of Long-Term Debt
¥531k
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
180m
JPY
Based on the financial report for Mar 31, 2024, Takara Bio Inc's Current Portion of Long-Term Debt amounts to 180m JPY.
What is Takara Bio Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
14%
Over the last year, the Current Portion of Long-Term Debt growth was 19%. The average annual Current Portion of Long-Term Debt growth rates for Takara Bio Inc have been 9% over the past three years , and 14% over the past ten years .
You don't have any saved screeners yet
